Indication
Limb-Girdle Muscular Dystrophies
1 clinical trial
2 products
Clinical trial
An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular DystrophiesStatus: Completed, Estimated PCD: 2016-10-05
Product
PlaceboProduct
ATYR1940